Funds

AST T. Rowe Price Growth Opportunities Portfolio

0P0000ZRO5

AST T. Rowe Price Growth Opportunities Portfolio

Actions
  • Price (--)--
  • Today's Change--
  • 1 Year change--
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Total returns on $10,000

5Y
AST T. Rowe Price Growth Opps
Fund
Allocation--70% to 85% Equity
Morningstar category
Morningstar Mod Tgt Risk TR USD
Benchmark index

Profile and investment

Fund typeOpen Ended Investment Company
Investment style (stocks)Market Cap: Large
Investment Style: Blend
Investment style (bonds)Credit Quality: Mid
Interest-Rate Sensitivity: Mod
Morningstar categoryAllocation--70% to 85% Equity
Launch date10 Feb 2014
Price currencyUSD
DomicileUnited States
Symbol--
Manager & start date
Charles Shriver
10 Feb 2014
Toby Thompson
10 Feb 2014
Pricing frequencyDaily
Total net assets
3.62bn USD
As of Jun 30 2021
Share class size
3.62bn USD
As of Jun 30 2021
Net expense ratio0.99%
Front end load--
Deferred load--
Maximum Redemption Fee--
Min. initial investment0.00
USD
Min. additional investment--
Initial IRA--
Additional IRA--
Available for saleUnited States
More ▼

Top 5 holdings

Top 5 holdings as a per cent of portfolio
17.06%13.31%1.36%14.67%
Category average% Net assets% Short% Long
Company1 year changePortfolio weightShort allocationLong allocation
Prudential Core Ultra Short Bond--10.71%
Cme Cdx Ig S28 1.00% 06/20/22 Effective:03/20/17;maturity:06/20/22 Sell Pro--1.39%
Cme Cdx Ig S28 1.00% 06/20/22 Effective:03/20/17;maturity:06/20/22 Sell Pro---1.36%
Amazon.com Inc
AMZN:NSQ
+7.12%1.30%
Microsoft Corp
MSFT:NSQ
+34.32%1.27%
Per cent of portfolio in top 5 holdings: 13.31%
Top 10 Holdings

Diversification

Asset type

Asset type

US stock49.68%
Non-US stock24.84%
Cash12.96%
US bond11.73%
Non-US bond0.63%
Other0.15%

Top 5 sectors

Equity
Fixed income
Technology12.90%
Financial Services12.09%
Healthcare10.73%
Consumer Cyclical8.86%
Industrials8.01%
Other22.01%

Top 5 regions

United States49.68%
Eurozone6.85%
United Kingdom4.04%
Japan4.02%
Emerging Asia2.84%
Other7.15%
Sector and region weightings are calculated using only long position holdings of the portfolio.
The performance data shown in tables and graphs on this page is calculated in USD of the fund/index/average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.
All managed funds data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2021
All Rights reserved
© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.